- LATEST
- WEBSTORY
- TRENDING
BUSINESS
Zydus Cadila gets USFDA nod for skin ointment, stomach ailment drug
Zydus Cadila has received final approval from the US health regulator to market Nystatin ointment and Omeprazoleand Sodium Bicarbonate capsules.
Updated : May 28, 2018, 12:04 PM IST
 "Zydus-Cadila-Plant")
TRENDING NOW
)
AR Rahman, Saira Banu's daughter Raheema opens up on parents' divorce being linked to Mohini Dey: 'Always remember...'
)
Riddhima Kapoor Sahni reveals Rishi Kapoor's last two wishes: 'He wanted to see Ranbir Kapoor getting...'
)
Sana Khan, former Bigg Boss contestant, actress announces 2nd pregnancy with Anas Saiyad: 'Only Allah has power to..'
)
'Good to be back': After breaking up with Malaika Arora, Arjun Kapoor reunites with his 'partner-in-crime after ages'
)
'Your dance lightens up...': Little girl's dance on 'Tere Bina na Guzara E' steals hearts online, WATCH viral video
)
Meet Imsha Rehman, Pakistani TikTok star who deactivated her accounts after video leak and Minahil Malik's MMS
)
This Pakistani Influencer's private video leaked online, days after Minahil Malik and Insha Rehman's clips
)
32-year-old superstar forcibly kissed 15-year-old co-star; left her traumatised, crying; later laughed about it saying..
)
Amid Aishwarya Rai-Abhishek Bachchan divorce rumours, Jaya Bachchan says 'not my daughter' in viral video
)
Telecom rules to change from January 1, Mukesh Ambani's Jio, Airtel, Vi, BSNL will be affected due to...
)
Mukesh Ambani's SUPERHIT plan for Jio users, offers unlimited 5G access for 1 year for just Rs...
)
AR Rahman's bassist Mohini Dey reacts to her split linked with composer's divorce with Saira Banu: 'I know exactly..'
)
Gandii Baat, XXX actress Aabha Paul sets Instagram on fire with hot photos
)
Good news for Delhi-NCR residents, travel time from Noida to Gurugram to be reduced as new train service will...
)
Meet Mathira Khan, Pakistani influencer whose private video leaked after Minahil Malik, Imsha Rehman
Zydus Cadila has received final approval from the US health regulator to market Nystatin ointment and Omeprazoleand Sodium Bicarbonate capsules.
Nystatin ointment is used to treat fungal skin infections.
Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Nystatin Ointment USP, 100,000 units per gram, the company said in a BSE filing.
Zydus Cadila said the drug will be produced at the group's Topical manufacturing facility at Moraiya, Ahmedabad.
The group has also received final approval to market Omeprazoleand Sodium Bicarbonate Capsules, 20 mg/1100 mg and 40 mg/1100 mg, used to treat certain stomach and esophagus problems (such as acid reflux, ulcers).
The group has more than 190 approvals, and so far filed over 320 abbreviated new drug applications (ANDAs) since it started filings in 2003-04.
Shares of Cadila Healthcare, the listed entity of the group, were trading 4.34 down per cent at Rs 365.90 per scrip on BSE.
